Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENIR-PEV: Lamivudine PrEP for Infants
NCT03869944Phase 2Unknown
- Sponsor
- ANRS
- Start
- Dec 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lamivudine in human immunodeficiency virus infection (HIV), sponsored by ANRS. Status: unknown.
02
Drugs
lamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03869944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03869944.